ResearcherThomas Jefferson UniversityActive in the last 2 years

Babar Bashir

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6843-1179; OpenAlex author ID A5070439273. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 3

Cancer Vaccination and Immune-Based Approaches in Pancreatic Cancer. Co-author DOI 10.3390/cancers17142356 ↗
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. Co-author DOI 10.1186/s13014-024-02457-y ↗
Pancreatic Adenocarcinoma: An Evolving Yet Unimpressive Treatment Landscape. Co-author DOI 10.1200/op.22.00620 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Adam Christopher Mueller · 2 shared papers, 2023–2024 · strength 0.57
- Paper Pancreatic Adenocarcinoma: An Evolving Yet Unimpressive Treatment Landscape. DOI 10.1200/op.22.00620 ↗
- Paper Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. DOI 10.1186/s13014-024-02457-y ↗
Adam Eugene Snook · 1 shared paper, 2025 · strength 0.33
- Paper Cancer Vaccination and Immune-Based Approaches in Pancreatic Cancer. DOI 10.3390/cancers17142356 ↗
Matthew Doran Bloom · 1 shared paper, 2025 · strength 0.33
- Paper Cancer Vaccination and Immune-Based Approaches in Pancreatic Cancer. DOI 10.3390/cancers17142356 ↗
Spencer Poiset · 1 shared paper, 2024 · strength 0.18
- Paper Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. DOI 10.1186/s13014-024-02457-y ↗
Atrayee Basu Mallick · 1 shared paper, 2024 · strength 0.18
- Paper Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. DOI 10.1186/s13014-024-02457-y ↗
Daniel Lin · 1 shared paper, 2024 · strength 0.18
- Paper Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. DOI 10.1186/s13014-024-02457-y ↗
James A. Posey · 1 shared paper, 2024 · strength 0.18
- Paper Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. DOI 10.1186/s13014-024-02457-y ↗
Harish Lavu · 1 shared paper, 2024 · strength 0.18
- Paper Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. DOI 10.1186/s13014-024-02457-y ↗
Charles J. Yeo · 1 shared paper, 2024 · strength 0.18
- Paper Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. DOI 10.1186/s13014-024-02457-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.